{"id":"W2776657901","doi":"10.1136/rmdopen-2017-000592","title":"Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2","year":2017,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"Novartis Pharma","keywords":"Medicine; Ankylosing spondylitis; Secukinumab; Physical therapy; Spondylitis; Signs and symptoms; Measure (data warehouse); Internal medicine; Arthritis; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003483533,0.0009510127,0.001542416,0.0002416716,0.0003316123,0.0008945441,0.0005406023,0.0009775045,0.002366937],"category_scores_gemma":[0.001187351,0.0002819693,0.001686638,0.0002673829,0.0005674309,0.0006853796,0.0002981994,0.002144567,0.0005619448],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005193152,"about_ca_system_score_gemma":0.0006580022,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004594888,"about_ca_topic_score_gemma":0.001061801,"domain_scores_codex":[0.99923,0.0003671937,0.00006273352,0.00007612244,0.0001293957,0.0001345704],"domain_scores_gemma":[0.9989178,0.0001925482,0.0003859441,0.00009646561,0.0001111056,0.0002961172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8006004,0.03505795,0.01161528,0.001700619,0.003143214,0.0002159148,0.0003573956,0.001034858,0.04126644,0.0002066559,0.004654033,0.1001472],"study_design_scores_gemma":[0.4107022,0.5372844,0.04057659,0.00009437171,0.001133609,0.0003666159,0.00006735713,0.0007119948,0.006443499,0.00009887383,0.002478836,0.00004161896],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9920201,0.005053047,0.0003922546,0.0003068866,0.0001066143,0.0004816185,0.0006436254,0.00007947785,0.000916375],"genre_scores_gemma":[0.9940024,0.001611117,0.000598608,0.0005247236,0.0001747622,0.0006014333,0.001178869,0.00002137497,0.001286585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003483533,"threshold_uncertainty_score":0.0184229,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03354987507514975,"score_gpt":0.3117454080993967,"score_spread":0.2781955330242469,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}